3-Bromo-2-methylbenzoic acid | CAS:76006-33-2

We serve 3-Bromo-2-methylbenzoic acid CAS:76006-33-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Bromo-2-methylbenzoic acid

Chemical Name:3-Bromo-2-methylbenzoic acid
CAS.NO:76006-33-2
Synonyms:3-Bromo-2-methylbenzoic acid
3-Bromo-o-toluic Acid
2-methyl-3-bromobenzoic acid
3-bromo-2-methylbenzenecarboxylic acid
2-Bromo-6-carboxytoluene
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Boiling Point 316.1±30.0 °C at 760 mmHg
Melting Point 152-156 °C(lit.)
Molecular Formula C8H7BrO2
Molecular Weight 215.044
Flash Point 145.0±24.6 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.595
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-Bromo-2-methylbenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-6-carboxytoluene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methyl-3-bromobenzoic acid Use and application,2-Bromo-6-carboxytoluene technical grade,usp/ep/jp grade.


Related News: Although bird flu poses more of a danger to poultry than humans — it is not easily transmissible among people — the World Health Organization has called on countries to be on guard because the virus can mutate into a transmissible form and has the potential to cause a pandemic.6,7-bis(2-methoxyethoxy)-1H-quinazolin-4-one manufacturer For example, an active ingredient to relieve pain is included in a painkiller.Ethyl 4-acetoxy-2-(ethylthio)-6,7-difluoroquinoline-3-carboxylate supplier With the onset of the DMF system for APIs, the concentration of the API industry will further increase.Aminosalicylate Sodium vendor Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it.